AllianzIM U.S. Equity Buffer10 Oct ETF (BATS:OCTT – Get Free Report) was the target of a significant decline in short interest in August. As of August 31st, there was short interest totaling 485 shares, a decline of 68.6% from the August 15th total of 1,546 shares. Based on an average daily trading volume, of 2,111 shares, the days-to-cover ratio is currently 0.2 days. Currently, 0.0% of the shares of the stock are sold short.
AllianzIM U.S. Equity Buffer10 Oct ETF Stock Up 0.7%
Shares of BATS OCTT opened at $48.00 on Friday. The firm has a market capitalization of $57.60 million, a P/E ratio of 23.90 and a beta of 0.59. The stock’s 50-day simple moving average is $47.36 and its two-hundred day simple moving average is $45.69. AllianzIM U.S. Equity Buffer10 Oct ETF has a twelve month low of $41.51 and a twelve month high of $48.10.
Institutional Inflows and Outflows
An institutional investor recently bought a new stake in AllianzIM U.S. Equity Buffer10 Oct ETF stock. JPMorgan Chase & Co. acquired a new position in AllianzIM U.S. Equity Buffer10 Oct ETF (BATS:OCTT – Free Report) during the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 9,601 shares of the company’s stock, valued at approximately $409,000. JPMorgan Chase & Co. owned about 0.71% of AllianzIM U.S. Equity Buffer10 Oct ETF at the end of the most recent quarter.
About AllianzIM U.S. Equity Buffer10 Oct ETF
The AllianzIM U.S. Large Cap Buffer10 Oct ETF (OCTT) is an exchange-traded fund that is based on the S&P 500 index. The fund aims for specific buffered losses and capped gains on the S&P 500 index over a specific holdings period. The actively-managed fund holds options and collateral. OCTT was launched on Sep 20, 2020 and is managed by Allianz.
See Also
- Five stocks we like better than AllianzIM U.S. Equity Buffer10 Oct ETF
- Block Makes a Federal Trust Bank Move That Could Reshape Its Fintech Model
- Kroger’s Textbook Entry for Buy-and-Hold Investors
- AST SpaceMobile Looks to Extend Its 30-Day FCC Satellite Testing Window
- Amgen Drops 10% on a Trial It Didn’t Even Run
Receive News & Ratings for AllianzIM U.S. Equity Buffer10 Oct ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AllianzIM U.S. Equity Buffer10 Oct ETF and related companies with MarketBeat.com's FREE daily email newsletter.
